Liposomes as Anticancer Therapeutic Drug Carrier’s Systems: More than a Tour de Force

Author(s): Mahfoozur Rahman, Sarwar Beg, Amita Verma, Imran Kazmi, Farhan Jalees Ahmed, Vikas Kumar, Firoz Anwar, Sohail Akhter*

Journal Name: Current Nanomedicine
Formerly Recent Patents on Nanomedicine

Volume 10 , Issue 2 , 2020

Become EABM
Become Reviewer

Graphical Abstract:


A liposome is a spherical vesicle composed of a bilayer of lipid with central aqueous cavity. Liposomes are the first nano vesicular drug delivery carriers, which are successfully translated into real-time clinical application and gained great potential in the past 30 years. The characteristics of liposomes to encapsulate both hydrophilic and hydrophobic drugs, their biocompatibility and biodegradability make it attractive nanocarriers in drug delivery area. Apart from this, great technical advancement has been made to develops second-generation liposomes named as stealth liposomes, cationic liposomes, triggered release liposomes and ligand targeted liposomes. This led to widespread use of liposomes in various areas including anticancer therapeutics, diagnostics and imaging agents. Therefore, the presents review article made an extensive discussion of various liposomes and its applications in cancer treatment.

Keywords: Phospholipids, Liposomes, ligand targeted liposomes, Cancer, Anticancer drug, and Doxil.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2020
Page: [178 - 185]
Pages: 8
DOI: 10.2174/2468187309666190618171332

Article Metrics

PDF: 12